Anixa Biosciences, Inc.ANIXNASDAQ

Revenue (LTM)

Net Income (LTM)

$-11M

+13.0% YoY

Free Cash Flow

$-7M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25
Revenue	1	0	0	0	0
Gross Profit	0	0	0	0	-0
Operating Income	-13	-14↓5.6%	-11↑20.6%	-14↓25.6%	-12↑15.4%
Net Income	-13	-14↓5.0%	-10↑27.8%	-13↓28.0%	-11↑13.0%
EBITDA	-13	-14↓5.0%	-11↑20.1%	-13↓15.5%	-12↑7.6%
EPS Diluted	-0.45	-0.45↓0.0%	-0.32↑28.9%	-0.39↓21.9%	-0.34↑12.8%

Metric	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25
Cash & Equivalents	29	12↓57.6%	1↓92.6%	1↑38.9%	1↓2.1%
Total Current Assets	36	30↓16.1%	25↓16.0%	21↓15.8%	16↓25.6%
Total Assets	36	30↓16.1%	26↓16.1%	22↓15.4%	16↓25.5%
Total Current Liabilities	1	2↑60.4%	2↓0.4%	3↑23.3%	2↓21.3%
Total Liabilities	1	2↑48.4%	2↓2.8%	3↑25.7%	2↓21.2%
Total Equity	35	29↓18.0%	24↓16.2%	20↓17.8%	15↓24.2%
Total Debt	0	0↓14.7%	0↓20.8%	0↑32.6%	0↓12.1%
Net Debt	-29	-12↑57.9%	-1↑93.9%	-1↓40.4%	-1↓0.1%

Metric	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25
Operating Cash Flow	-5	-6↓31.5%	-6↑4.4%	-7↓18.1%	-7↑2.2%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-5	-6↓31.5%	-6↑4.4%	-7↓18.1%	-7↑2.2%
Stock-Based Comp	8	6↓20.0%	4↓26.3%	4↓0.0%	4↓16.7%
Net Change in Cash	23	-17↓173.8%	-11↑31.7%	0↑103.1%	-0↓107.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance